ESC 365 - Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

EACVI Premium Access

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Session: Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging

Topic: Myocardial Disease

Speaker: Doctor A. Ioannou (Greater London, GB)

Event: EACVI 2023

Congress Presentation

Add to my library

About the speaker

Doctor Adam Ioannou

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

1 follower

6 more presentations in this session

Prospective cascade screening for transthyretin amyloid cardiomyopathy in patients undergoing spinal stenosis surgery: results of the CASS (Cardiac Amyloidosis in Spinal Stenosis) study.

Speaker: Doctor P. Debonnaire (Brugge, BE)

Dapagliflozin improves radial and longitudinal strain, increases pAMPK and reduces myocardial and renal NF-kB expression in preclinical models of doxorubicin cardiotoxicity through NLRP3 and Myd-88

Speaker: Doctor N. Maurea (Naples, IT)

Impact of myocardial inflammation on quantitative myocardial perfusion at long-term follow-up - a descriptive hybrid PET/MR myocarditis study

Speaker: Professor R. Buechel (Zurich, CH)

Hepatic t1 mapping: a new easily obtained biomarker for heart failure patients undergoing cardiac magnetic resonance.

Speaker: Doctor R. Reis Santos (Lisbon, PT)

Cardiac magnetic resonance phenotypes and cardiovascular prognosis in classical vs cardiac variant of Fabry disease

Speaker: Doctor G. Guida (San Donato Milanese, IT)

Access the full session

Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging

Speakers: Doctor A. Ioannou, Doctor P. Debonnaire, Doctor N. Maurea, Professor R. Buechel, Doctor R. Reis Santos...

About the event

EACVI 2023

10 May - 12 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources